← Evidence map

ArticleAnnals of internal medicine2023

In HF, with or without PAD, dapagliflozin reduced a composite of worsening HF or CV death and did not increase amputations.

Debabrata MukherjeePubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 37665990